S&P 500   3,375.89 (+0.07%)
DOW   27,955.21 (+0.21%)
QQQ   272.43 (-0.02%)
AAPL   459.10 (-0.20%)
MSFT   208.71 (+0.00%)
FB   261.16 (-0.05%)
GOOGL   1,511.33 (-0.35%)
AMZN   3,149.03 (-0.38%)
NVDA   461.02 (+0.72%)
CGC   17.31 (-0.06%)
BABA   253.43 (-0.11%)
TSLA   1,650.45 (+1.82%)
GE   6.67 (+1.06%)
MU   46.01 (-0.28%)
AMD   81.36 (-0.59%)
T   30.04 (+0.43%)
F   7.08 (+0.71%)
ACB   10.87 (+6.78%)
GILD   68.68 (+0.73%)
NFLX   482.35 (+0.21%)
DIS   130.33 (-0.48%)
BAC   26.53 (+0.68%)
BA   178.21 (+1.99%)
S&P 500   3,375.89 (+0.07%)
DOW   27,955.21 (+0.21%)
QQQ   272.43 (-0.02%)
AAPL   459.10 (-0.20%)
MSFT   208.71 (+0.00%)
FB   261.16 (-0.05%)
GOOGL   1,511.33 (-0.35%)
AMZN   3,149.03 (-0.38%)
NVDA   461.02 (+0.72%)
CGC   17.31 (-0.06%)
BABA   253.43 (-0.11%)
TSLA   1,650.45 (+1.82%)
GE   6.67 (+1.06%)
MU   46.01 (-0.28%)
AMD   81.36 (-0.59%)
T   30.04 (+0.43%)
F   7.08 (+0.71%)
ACB   10.87 (+6.78%)
GILD   68.68 (+0.73%)
NFLX   482.35 (+0.21%)
DIS   130.33 (-0.48%)
BAC   26.53 (+0.68%)
BA   178.21 (+1.99%)
S&P 500   3,375.89 (+0.07%)
DOW   27,955.21 (+0.21%)
QQQ   272.43 (-0.02%)
AAPL   459.10 (-0.20%)
MSFT   208.71 (+0.00%)
FB   261.16 (-0.05%)
GOOGL   1,511.33 (-0.35%)
AMZN   3,149.03 (-0.38%)
NVDA   461.02 (+0.72%)
CGC   17.31 (-0.06%)
BABA   253.43 (-0.11%)
TSLA   1,650.45 (+1.82%)
GE   6.67 (+1.06%)
MU   46.01 (-0.28%)
AMD   81.36 (-0.59%)
T   30.04 (+0.43%)
F   7.08 (+0.71%)
ACB   10.87 (+6.78%)
GILD   68.68 (+0.73%)
NFLX   482.35 (+0.21%)
DIS   130.33 (-0.48%)
BAC   26.53 (+0.68%)
BA   178.21 (+1.99%)
S&P 500   3,375.89 (+0.07%)
DOW   27,955.21 (+0.21%)
QQQ   272.43 (-0.02%)
AAPL   459.10 (-0.20%)
MSFT   208.71 (+0.00%)
FB   261.16 (-0.05%)
GOOGL   1,511.33 (-0.35%)
AMZN   3,149.03 (-0.38%)
NVDA   461.02 (+0.72%)
CGC   17.31 (-0.06%)
BABA   253.43 (-0.11%)
TSLA   1,650.45 (+1.82%)
GE   6.67 (+1.06%)
MU   46.01 (-0.28%)
AMD   81.36 (-0.59%)
T   30.04 (+0.43%)
F   7.08 (+0.71%)
ACB   10.87 (+6.78%)
GILD   68.68 (+0.73%)
NFLX   482.35 (+0.21%)
DIS   130.33 (-0.48%)
BAC   26.53 (+0.68%)
BA   178.21 (+1.99%)
Log in

NASDAQ:GHSIGuardion Health Sciences Stock Price, Forecast & News

$0.35
-0.04 (-9.21 %)
(As of 08/14/2020 01:49 PM ET)
Add
Compare
Today's Range
$0.35
Now: $0.35
$0.38
50-Day Range
$0.40
MA: $0.43
$0.49
52-Week Range
$0.17
Now: $0.35
$0.95
Volume70,694 shs
Average Volume8.63 million shs
Market Capitalization$30.32 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.19
Guardion Health Sciences, Inc., a specialty health sciences company, develops, formulates, and distributes condition-specific medical foods in the United States and internationally. It operates in two segments, Medical Foods and Vision Testing Diagnostics. The Medical Foods segment offers Lumega-Z, a medical food that replenishes and restores the macular protective pigment; MapcatSF, a medical device that measures the macular pigment optical density; and GlaucoCetin, a vision-specific medical food to support and protect the mitochondrial function of optic nerve cells, as well as improve blood flow in the ophthalmic artery in patients with glaucoma. The Vision Testing Diagnostics segment develops, manufactures, and sells equipment and supplies for standardized vision testing for use by eye doctors in clinical trials, real-world vision evaluation, and industrial vision testing. Its products include VectorVision CSV-1000, an instrument for contrast sensitivity testing; and ESV-3000 ETDRS, a device for early treatment diabetic retinopathy study in visual acuity testing. The company distributes its products through direct sales force, as well as through its guardionhealth.com Website. Guardion Health Sciences, Inc. was founded in 2009 and is headquartered in San Diego, California.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.50 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:GHSI
CUSIPN/A
CIKN/A
Phone858-605-9055

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$900,000.00
Book Value$0.16 per share

Profitability

Net Income$-10,880,000.00
Net Margins-1,307.08%

Miscellaneous

Employees19
Market Cap$30.32 million
Next Earnings Date11/12/2020 (Estimated)
OptionableNot Optionable
$0.35
-0.04 (-9.21 %)
(As of 08/14/2020 01:49 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive GHSI News and Ratings via Email

Sign-up to receive the latest news and ratings for GHSI and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Guardion Health Sciences (NASDAQ:GHSI) Frequently Asked Questions

How has Guardion Health Sciences' stock price been impacted by COVID-19 (Coronavirus)?

Guardion Health Sciences' stock was trading at $0.39 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, GHSI shares have decreased by 9.7% and is now trading at $0.3521.
View which stocks have been most impacted by COVID-19
.

When is Guardion Health Sciences' next earnings date?

Guardion Health Sciences is scheduled to release its next quarterly earnings announcement on Thursday, November 12th 2020.
View our earnings forecast for Guardion Health Sciences
.

How were Guardion Health Sciences' earnings last quarter?

Guardion Health Sciences Inc (NASDAQ:GHSI) posted its quarterly earnings data on Monday, August, 12th. The company reported ($0.14) earnings per share (EPS) for the quarter. The business had revenue of $0.26 million for the quarter. Guardion Health Sciences had a negative return on equity of 123.03% and a negative net margin of 1,307.08%.
View Guardion Health Sciences' earnings history
.

Has Guardion Health Sciences been receiving favorable news coverage?

News stories about GHSI stock have been trending somewhat negative this week, according to InfoTrie. The research group identifies negative and positive press coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Guardion Health Sciences earned a media sentiment score of -1.6 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the company's share price in the next several days.
View the latest news about Guardion Health Sciences
.

Are investors shorting Guardion Health Sciences?

Guardion Health Sciences saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 3,010,000 shares, an increase of 37.4% from the April 15th total of 2,190,000 shares. Based on an average trading volume of 10,580,000 shares, the days-to-cover ratio is currently 0.3 days.
View Guardion Health Sciences' Short Interest
.

Who are some of Guardion Health Sciences' key competitors?

What other stocks do shareholders of Guardion Health Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Guardion Health Sciences investors own include Ibio (IBIO), Biocept (BIOC), Onconova Therapeutics (ONTX), Tonix Pharmaceuticals (TNXP), Advaxis (ADXS), FuelCell Energy (FCEL), Ocugen (OCGN), Chesapeake Energy (CHKAQ), Chesapeake Energy (CHKAQ) and Heat Biologics (HTBX).

Who are Guardion Health Sciences' key executives?

Guardion Health Sciences' management team includes the following people:
  • Michael Favish, Pres, CEO & Chairman (Age 70)
  • Mr. John W. Townsend, Controller & Chief Accounting Officer (Age 57)
  • Dr. David W. Evans, Chief Science Officer & Director (Age 63)
  • Mr. Vincent J. Roth, Gen. Counsel & Corp. Sec. (Age 51)

When did Guardion Health Sciences IPO?

(GHSI) raised $6 million in an IPO on Friday, April 5th 2019. The company issued 1,500,000 shares at $4.00 per share. WallachBeth Capital and Westpark Capital acted as the underwriters for the IPO.

What is Guardion Health Sciences' stock symbol?

Guardion Health Sciences trades on the NASDAQ under the ticker symbol "GHSI."

Who are Guardion Health Sciences' major shareholders?

Guardion Health Sciences' stock is owned by a variety of retail and institutional investors. Top institutional investors include Virtu Financial LLC (0.21%), Integrated Wealth Concepts LLC (0.14%) and UBS Group AG (0.11%).

Which institutional investors are buying Guardion Health Sciences stock?

GHSI stock was bought by a variety of institutional investors in the last quarter, including Virtu Financial LLC, Integrated Wealth Concepts LLC, and UBS Group AG.

How do I buy shares of Guardion Health Sciences?

Shares of GHSI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Guardion Health Sciences' stock price today?

One share of GHSI stock can currently be purchased for approximately $0.35.

How big of a company is Guardion Health Sciences?

Guardion Health Sciences has a market capitalization of $30.15 million and generates $900,000.00 in revenue each year. Guardion Health Sciences employs 19 workers across the globe.

What is Guardion Health Sciences' official website?

The official website for Guardion Health Sciences is www.guardionhealth.com.

How can I contact Guardion Health Sciences?

Guardion Health Sciences' mailing address is 15150 AVENUE OF SCIENCE SUITE 200, SAN DIEGO CA, 92128. The company can be reached via phone at 858-605-9055 or via email at [email protected]

This page was last updated on 8/14/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.